About Yuhan. Corporate Overview CEO’s Greeting Vision History Affiliates Location

Yuhan Corporation (Korean: 주식회사 유한양행; Hanja: 株式會社 柳韓洋行; RR: Jusik Hoesa Yuhan Yanghaeng) is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962.

A leading pharmaceutical company dedicated to addressing global health challenges since 1926. Yuhan USA is actively searching for business development and strategic partnership …

True to the company’s founding mission, Yuhan focuses its R&D efforts on developing the kinds of products people need most. By developing therapies for treating inflammatory, autoimmune, oncologic and metabolic diseases, Yuhan has significantly advanced the science and understanding of these prevalent disease processes.

2023年6月1日 · Yuhan（柳韩洋行）是一家韩国制药和化工企业，总部位于汉城铜雀区，于1926年由伊尔汉柳创立，并于1962年在韩国证券交易所上市。 2023年一季报显示，第一季度营业利润为 195 亿韩元 (约合人民币 1.1 亿元)，同比增加286.9%，增长率达到了三位数。 同期，销售额为 4314 亿韩元，增长了 8.5%。 在今年第一季度的销售额中，专利技术收入为72 亿韩元，同比增长了 393%。 另一方面，广告费同比减少 21.5%达到 172亿韩元。 从业务部门的表现来看，处 …

2024年1月9日，Yuhan Corp.（柳韩洋行）在2024 摩根大通医疗保健大会（J.P.Morgan Healthcare Conference）大会上通过展示其成为全球制药公司50强的雄心，吸引外国投资者和潜在药物开发合作伙伴的目光。

Since 1926, Yuhan Corporation has upheld its commitment to transparent management and extensive research, striving to develop innovative drugs that positively impact people. With over 300 scientists at Yuhan Research Institute, we are striving to become a patient-centered global leading pharmaceutical company.

了解Yuhan Corp. (Yuhan Corp.)公司的药物管线，治疗领域，技术平台，以及它的122项临床试验, 65篇新闻和82篇文献，疾病领域:肿瘤，内分泌与代谢疾病，神经系统疾病，感染，免疫系统疾病，技术平台:小分子化药，生物药，未知，融合蛋白，益生菌，药物:盐酸瑞伐拉 ...

Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells...

2024年1月9日，Yuhan Corp.（柳韩洋行）在2024 摩根大通医疗保健大会（J.P.Morgan Healthcare Conference）大会上通过展示其成为全球制药公司50强的雄心，吸引外国投资者和潜在药物开发合作伙伴的目光。